Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, November 28 2014 12:10pm ET - U.S. Markets close in 3 hours and 50 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drugs - Generic News
Latest News
Friday, Nov 28, 2014
·Will Avanir Pharmaceuticals (AVNR) Continue to Surge Higher? - Fri 5:37 am ET
·SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Salix Pharmaceuticals of Class Action Lawsuit and Upcoming Deadline -- SLXP
GlobeNewswire - Fri 3:00 am ET
Wednesday, Nov 26, 2014
·Avanir to Provide More Human-Factor Data for Migraine Treatment
at The Wall Street Journal Online - Wed 6:13 pm ET
·FDA rejects Avanir's migraine drug-device
Reuters - Wed 5:30 pm ET
·Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA
PR Newswire - Wed 4:54 pm ET
·INVESTOR ALERT: Class Action Lawsuit Against Salix Pharmaceuticals, Ltd. Announced by Law Offices of Howard G. Smith
Business Wire - Wed Nov 26
·Jefferies Raises Zoetis Price Target, Says Consolidation Continues To Look Likely
- Wed Nov 26
·Ackman's Pershing Square still holds 26.6 million Allergan shares
Reuters - Wed Nov 26
·pSivida CEO to Present at LD Micro Investor Conference
Business Wire - Wed Nov 26
·Why Actavis (ACT) Could Be an Impressive Growth Stock - Wed Nov 26
·Is Lannett Company (LCI) a Great Growth Stock? - Wed Nov 26
Tuesday, Nov 25, 2014
·EQUITY ALERT: The Rosen Law Firm Announces Filing of Securities Class Action Against Salix Pharmaceuticals, Ltd. - SLXP
GlobeNewswire - Tue Nov 25
·Neurocrine to Present at the 2014 Deutsche Bank BioFEST and the 26th Annual Piper Jaffray Healthcare Conference
PR Newswire - Tue Nov 25
·Salix Pharmaceuticals Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
Business Wire - Tue Nov 25
·Evoke Pharma to Present at LD Micro Conference
GlobeNewswire - Tue Nov 25
·Sophiris Bio to Present at the 26th Annual Piper Jaffray Healthcare Conference
Business Wire - Tue Nov 25
·Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC┬«
PR Newswire - Tue Nov 25
·Why Lannett (LCI) Could Be a Potential Winner - Tue Nov 25
Monday, Nov 24, 2014
·Actavis mulls job cuts, China expansion - Bloomberg
Reuters - Mon Nov 24
·American Homecare Federation launches new website
PR Newswire - Mon Nov 24
More Latest News...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
Domain Names From $6
$6 domains. Over 45 extensions. Loads of free extras at great prices!
M/A/R/C Research
Custom Research
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?